Sana Biotechnology Statistics
Total Valuation
SANA has a market cap or net worth of $399.42 million. The enterprise value is $348.82 million.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SANA has 225.02 million shares outstanding. The number of shares has increased by 18.69% in one year.
Current Share Class | 225.02M |
Shares Outstanding | 225.02M |
Shares Change (YoY) | +18.69% |
Shares Change (QoQ) | +0.38% |
Owned by Insiders (%) | 8.91% |
Owned by Institutions (%) | 60.29% |
Float | 134.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.58 |
P/TBV Ratio | 7.88 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.41.
Current Ratio | 3.54 |
Quick Ratio | 3.36 |
Debt / Equity | 0.41 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -99.17% and return on invested capital (ROIC) is -45.61%.
Return on Equity (ROE) | -99.17% |
Return on Assets (ROA) | -31.82% |
Return on Invested Capital (ROIC) | -45.61% |
Return on Capital Employed (ROCE) | -59.59% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.38M |
Employee Count | 194 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.31% in the last 52 weeks. The beta is 1.78, so SANA's price volatility has been higher than the market average.
Beta (5Y) | 1.78 |
52-Week Price Change | -79.31% |
50-Day Moving Average | 2.21 |
200-Day Moving Average | 3.46 |
Relative Strength Index (RSI) | 47.51 |
Average Volume (20 Days) | 3,928,121 |
Short Selling Information
The latest short interest is 40.25 million, so 17.89% of the outstanding shares have been sold short.
Short Interest | 40.25M |
Short Previous Month | 39.89M |
Short % of Shares Out | 17.89% |
Short % of Float | 30.01% |
Short Ratio (days to cover) | 10.97 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -271.47M |
Pretax Income | -244.90M |
Net Income | -266.76M |
EBITDA | -255.97M |
EBIT | -271.47M |
Earnings Per Share (EPS) | -$1.16 |
Full Income Statement Balance Sheet
The company has $152.50 million in cash and $101.90 million in debt, giving a net cash position of $50.60 million or $0.22 per share.
Cash & Cash Equivalents | 152.50M |
Total Debt | 101.90M |
Net Cash | 50.60M |
Net Cash Per Share | $0.22 |
Equity (Book Value) | 250.50M |
Book Value Per Share | 1.12 |
Working Capital | 115.38M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$223.15 million and capital expenditures -$33.43 million, giving a free cash flow of -$256.58 million.
Operating Cash Flow | -223.15M |
Capital Expenditures | -33.43M |
Free Cash Flow | -256.58M |
FCF Per Share | -$1.14 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |